North America Vascular Stent Market

North America Vascular Stent Market Size (2024 to 2029)

The size of the Vascular Stent Market in North America is valued at USD 5.09 billion in 2024 and is expected to be growing at a CAGR of 8.3%, to touch 7.58 billion by 2029. 

Vascular stenting comprises the employment of a minor mesh wire tube inside the blood vessel to help keep it open. Furthermore, the technique is way less intrusive than other available surgical procedures for the treatment of Cardio Vascular Diseases (CVD) and does not require general anesthesia.

The crucial function of a vascular stent is to help keep the congested artery open, which results in enhanced and improved blood flow to the heart. The clean arteries and increased blood flow significantly reduce the odds of a heart attack.

The growth of the North American Vascular Stent Market is mainly driven by consumers' demand to choose vascular stents as an alternative to available surgical procedures such as bypass surgeries, owing to the lower invasiveness of the process. It is further complemented by the increasing choice of cardiovascular surgeons to use vascular stents in treating CVDs. Other factors promoting the market growth include the growing incidence of cardiovascular ailments, the ever-increasing elderly populace, and the advance of bioabsorbable stents.

The market faces some constraints such as cases of product recalls and failures and strict regulations regarding the use of stents by government agencies.

This research report on the North America Vascular Stent Market has been segmented and sub-segmented into the following categories.

• By Product: Peripheral Stents, Coronary Stents, and EVAR Stent Grafts.
• By Type: Bare-Metal Stents, Drug-Eluting Stents, and Bioabsorbable Stents.
• By Mode of Delivery: Self-Expanding Stents and Balloon Expanding Stents.
• By Material: Metal and Polymer.
• By End User: Hospitals and Research Institutes.
• By Country: U.S, Canada and Rest of North America

Regional Analysis

North America region for vascular stent market was accounted for the largest share in 2023. Factors like the rising number of people suffering from obesity-related problems and growing incidences of cardiovascular diseases prompt market demand. 

In North America, the U.S. is leading the vascular stents market with the largest share due to the advancements in technology, augmenting demand for advanced devices to cater to the healthcare needs in the growing older people population and increasing occurrence rate of cardiovascular illness. In this country, around 8millions people are diagnosed with PAD, including 12-20% of the people who are 60 years and above.

Canadian vascular stent market is expected to witness substantial growth. It is also estimated to hold the second-largest market followed after the U.S. as advanced technologies incorporated with growing healthcare expenditure, which surge this region's market growth.

Notable companies leading the North American Vascular Stent Market profiled in this report are Medtronic, plc (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), STENTYS SA (France), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), Vascular Concepts (India), W. L. Gore and Associates (U.S.), C. R. Bard (U.S.), Endologix, Inc. (U.S.), Lombard Medical Technologies (U.K.), Translumina GmbH (Germany), and JOTEC GmbH (Germany).